abstract |
The present invention provides an agent for inhibiting or reducing the photoreceptor sensitivity of a substance that inhibits or inhibits ubiquitination, for example, a photoreceptor sensitivity that protects the retina, inhibits retinal degeneration, inhibits retinal aging, and/or inhibits hypersensitivity reactions inhibitor or attenuator. The present invention can be suitably used for, for example, age-related macular degeneration, retinitis pigmentosa, Leber's congenital amaurosis, Starger's disease, cone and rod dystrophy, diabetic retinopathy, macular edema, and retinal ischemia , photosensitive epilepsy, photosensitive epilepsy, mental disorders, solar retinopathy, visual fatigue, retinal degeneration, sleep disorders, migraine, light damage and other symptoms related to photoreception improvement or prevention. |